JESSICA HENDERSON: Open Payments
NPI 1467127902 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,475 in 95 payments from 16 companies in 2025. Trend: 2023 $1,451 · 2024 $1,258 · 2025 $2,475
Food & beverage: $2,305Education: $170
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $465 |
| Regeneron Healthcare Solutions, Inc. | 10 | $463 |
| ABBVIE INC. | 15 | $343 |
| Lilly USA, LLC | 10 | $246 |
| Novartis Pharmaceuticals Corporation | 9 | $186 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $164 |
| GENZYME CORPORATION | 1 | $125 |
| Incyte Corporation | 5 | $98 |
| Organon LLC | 6 | $92 |
| UCB, Inc. | 2 | $62 |
Products named: DUPIXENT, TREMFYA, RINVOQ, SKYRIZI, COSENTYX, LIBTAYO, ZEPBOUND, Winlevi.
Industry payments across MD — which companies pay providers there.
